AU2001291239A1 - Use of vitamin d2 compounds for alopecia - Google Patents

Use of vitamin d2 compounds for alopecia

Info

Publication number
AU2001291239A1
AU2001291239A1 AU2001291239A AU9123901A AU2001291239A1 AU 2001291239 A1 AU2001291239 A1 AU 2001291239A1 AU 2001291239 A AU2001291239 A AU 2001291239A AU 9123901 A AU9123901 A AU 9123901A AU 2001291239 A1 AU2001291239 A1 AU 2001291239A1
Authority
AU
Australia
Prior art keywords
alopecia
vitamin
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001291239A
Inventor
Melanie A. Blanchard
Patricia L. Mershimer
Honorate Stelmach
Scott E. Toner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of AU2001291239A1 publication Critical patent/AU2001291239A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
AU2001291239A 2000-10-06 2001-09-26 Use of vitamin d2 compounds for alopecia Abandoned AU2001291239A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US68457400A 2000-10-06 2000-10-06
US09684574 2000-10-06
PCT/US2001/029980 WO2002030430A1 (en) 2000-10-06 2001-09-26 Use of vitamin d2 compounds for alopecia

Publications (1)

Publication Number Publication Date
AU2001291239A1 true AU2001291239A1 (en) 2002-04-22

Family

ID=24748609

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001291239A Abandoned AU2001291239A1 (en) 2000-10-06 2001-09-26 Use of vitamin d2 compounds for alopecia

Country Status (2)

Country Link
AU (1) AU2001291239A1 (en)
WO (1) WO2002030430A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030095937A1 (en) * 2001-10-02 2003-05-22 Koeffler H. Philip Method for stimulating hair growth by administering vitamin D analogs
EP3603646B1 (en) 2009-08-14 2024-04-03 BPGbio, Inc. Vitamin d3 and analogs thereof for treating alopecia
GB201610910D0 (en) * 2016-06-22 2016-08-03 Paxman Coolers Ltd Composition and apparatus for treatment of chemotherapy induced alopecia

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE58277B1 (en) * 1983-05-09 1993-08-25 Wisconsin Alumni Res Found 1 , 25-dihydroxylated vitamin d2 compounds and intermediates in the preparation thereof
CZ280874B6 (en) * 1991-06-28 1996-04-17 University Of Miami Preparation for preventing alopecia
US6087350A (en) * 1997-08-29 2000-07-11 University Of Pittsburgh Of The Commonwealth System Of Higher Education Use of pretreatment chemicals to enhance efficacy of cytotoxic agents

Also Published As

Publication number Publication date
WO2002030430A1 (en) 2002-04-18

Similar Documents

Publication Publication Date Title
AU2002363005A1 (en) Derivatives of uk-2a
AU2001240115A1 (en) Method for the preparation of tetrahydrobenzothiepines
AU2001235691A1 (en) Use of paullone derivatives for making medicines
AU2002222853A1 (en) Therapeutic compounds
AU2557500A (en) Methods of making compounds
AU2001248777A1 (en) Vitamin d derivatives
AU2002223548A1 (en) Improved method for the biosynthesis of vitamin e
AU2001294258A1 (en) Method of purifying plavastatin
AU2001244108A1 (en) Formulations for states of dehydration
AU2001287711A1 (en) Method for measurement of the activity of NO-synthase
AU2001291239A1 (en) Use of vitamin d2 compounds for alopecia
AU2001262729A1 (en) 4-oxoimidazolidine-2-spiro-nitrogenous heterocycle compounds
AU2000267372A1 (en) Polyoxyethylene-polyoxypropylene vitamin e and process for preparation thereof
AU2002210816A1 (en) Process for preparation of beta-phenethylamine derivative
AU4886201A (en) Use of vitamin b1 as agents for controlling plant diseases
AU2000238755A1 (en) Dermatological compounds
AU2002222687A1 (en) Process for preparation of polyhydric alcohols
AU2001227095A1 (en) Processes for the preparation of carbapenem derivatives
AU2001258330A1 (en) New uses of imidazolylmethyl-pyridines
AU2002216038A1 (en) Preparation of monofluoroalkenes
AU2002224900A1 (en) Method for the preparation of dichlorodiarylmethanes
AU2002224032A1 (en) Processes for preparation of tetrahydronaphthalene derivatives
AU2001266362A1 (en) Processes for the preparation of pyrone compounds
AUPQ811200A0 (en) Treatment of alopecia
AU2001282428A1 (en) Stabilized derivatives of ascorbic acid -3-phosphate